Exova Group PLC Director/PDMR Shareholding (6684V)
2016年4月19日 - 10:00PM
RNSを含む英国規制内ニュース (英語)
TIDMEXO
RNS Number : 6684V
Exova Group PLC
19 April 2016
EXOVA GROUP PLC
Notification of transactions of Directors and PDMRs
19 April 2016
On 18 April 2016, awards in the form of nil cost awards
("Awards") taking the form of a nil cost option or conditional
award (as set out below) to acquire ordinary shares of 1 pence each
("Shares") in Exova Group plc (the "Company") were granted to
certain persons discharging managerial responsibilities ("PDMRs")
under the Exova Group plc Long Term Incentive Plan ("LTIP"), as set
out in column 3 in the table below.
The number of Shares subject to the Awards has been determined
by reference to the market value of a Share on 18 April 2016 (162
pence per Share). In addition, the Company has granted market value
options under the company share option plan section of the LTIP
("CSOP Option") over the number of Shares set out in column 4 of
the table below to Paul Barry, a PDMR. The exercise price of each
CSOP Option is 162 pence per Share, and has also been determined by
reference to the market value of a Share on 18 April 2016. The
number of Shares that is capable of exercise under the nil cost
option will be reduced by such number of Shares as has a market
value (at the date of exercise of the CSOP Option) equal to the
gain made on the exercise of the CSOP Option. Overall, the
participant's pre-tax economic gain from the nil cost option is the
same as if the CSOP Option was not in place.
1. Name 2. Status 3. Number of 4. Number of Shares under CSOP Option
Shares under
Nil Cost Option
------------------ ---------------- ----------------- ----------------------------------------
Ian El-Mokadem Director/PDMR 425,000 -
------------------ ---------------- ----------------- ----------------------------------------
Philip Marshall Director/PDMR 200,617 -
------------------ ---------------- ----------------- ----------------------------------------
Paul Barry PDMR 160,493 18,518
------------------ ---------------- ----------------- ----------------------------------------
Gary Brimmage PDMR 190,689* -
------------------ ---------------- ----------------- ----------------------------------------
Matthew Davies PDMR 106,179 -
------------------ ---------------- ----------------- ----------------------------------------
John Willox PDMR 126,543 -
------------------ ---------------- ----------------- ----------------------------------------
* Award granted in form of a conditional share award
The vesting of the Awards and the CSOP Options is subject to the
satisfaction of a performance condition set by the Remuneration
Committee of the Company. The Awards and CSOP Options will normally
vest and become exercisable on the later of the third anniversary
of grant and the assessment of the performance condition, subject
to continued employment. A total amount of GBP1 is payable on the
exercise of any nil cost option.
No consideration was paid for the grant of any of the above
awards.
This notification is made in accordance with DTR 3.1.4
For and on behalf of Exova Group plc
Date: 19 April 2016
Neil MacLennan
General Counsel & Company Secretary
Telephone: 0131 333 8053
About Exova
Exova is one of the world's leading laboratory-based testing
groups, trusted by organisations to test and advise on the safety,
quality and performance of their products and operations.
Headquartered in Edinburgh, UK, Exova operates 145 laboratories and
offices in 32 countries and employs around 4,500 people throughout
Europe, the Americas, the Middle East and Asia/Asia Pacific.
Exova's capabilities help to extend asset life, bring
predictability to applications, and shorten the time to market for
customers' products, processes and materials. With over 90 years'
experience, Exova specialises in testing across a number of key
sectors from health sciences to aerospace, transportation, oil and
gas, fire and construction.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHUKVARNVASAAR
(END) Dow Jones Newswires
April 19, 2016 09:00 ET (13:00 GMT)
Exova (LSE:EXO)
過去 株価チャート
から 6 2024 まで 7 2024
Exova (LSE:EXO)
過去 株価チャート
から 7 2023 まで 7 2024